NCT00430443View on ClinicalTrials.gov

Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

January 31, 2009

Conditions
Acute Lymphocytic LeukemiaAcute Myelogenous Leukemia
Interventions
DRUG

Liposomal Annamycin

3-day IV infusion

Trial Locations (3)

37237

Vanderbilt Children's Hospital, Nashville

80218

Denver Children's Hospital, Denver

85016

Phoenix Children's Hospital, Phoenix

Sponsors
All Listed Sponsors
lead

Callisto Pharmaceuticals

INDUSTRY